Krishna Institute of Medical Sciences Limited (KIMS Hospitals) announced its financial results for the second quarter of FY2027, reporting a significant 41.3% year-on-year increase in total revenue to INR 1,363 crores. EBITDA also saw a substantial rise of 34% year-on-year to INR 279 crores. The company highlighted growth across key parameters, including operational expansions and strategic acquisitions, contributing to its robust financial performance.
KIMS Hospitals Announces Strong Q2 FY27 Financials
Krishna Institute of Medical Sciences Limited, operating under the KIMS Hospitals brand, has released its financial results for the second quarter ending September 30, 2026. The company has demonstrated robust growth across key financial and operational metrics, underscoring its expansion strategies and market position.
Key Financial Highlights (Q2 FY27)
- Total Revenue: Reported at INR 1,363 crores, marking a significant 41.3% growth on a year-on-year basis and a 14% increase quarter-on-quarter.
- EBITDA: Stood at INR 279 crores, up 34% year-on-year and 16.3% quarter-on-quarter.
- EBITDA Margin: Recorded at 20.5%, compared to 20.1% in Q1 FY27 and 21.7% in Q2 FY26.
- Profit After Tax (PAT): Reached INR 76 crores in Q2 FY27, a substantial increase from INR 37 crores in Q1 FY27 and INR 72 crores in Q2 FY26.
- Consolidated EPS: At INR 1.8, showing an 8.5% year-on-year growth.
- Cash and Cash Equivalents: Totaled INR 420 crores as of September 30, 2026.
Operational Performance and Strategic Initiatives
The company also detailed its operational highlights, including an increase in average revenue per operating bed and per patient. KIMS Hospitals has been actively strengthening its network through strategic acquisitions and operational agreements.
Recent Acquisitions and Agreements:
- Acquisition of a 51% equity stake in Sarvottam Health Care Private Limited (KIMS Trust Hospital, Kakinada) for INR80 crores.
- Acquisition of a 6% stake in Ushahkal Abhinav Specialty Hospital, Sangli, Maharashtra, for INR15 crores.
- Expansion with KIMS Kompally (Secunderabad, 225 beds) and KIMS Sikhara (Guntur, 150 beds), with plans for phased integration.
- Entered into an O&M agreement with Arete Hospitals (Hyderabad, 300 beds) and Westfort Hospital (Thrissur, Kerala, 300 beds).
Other Key Developments
KIMS Hospitals emphasized its commitment to making healthcare accessible, noting the expansion of organ transplantation services to tier two and tier three cities. The company has also doubled the capacity of its KIMS Saveera Hospital in Anantapur to 500 beds, inaugurating new comprehensive oncology and mother-and-child blocks.
An international collaboration with NHS University Hospitals of Liverpool for research, clinical collaboration, education, and training was also highlighted.
Source: BSE
